NYSEARCA:XDIV Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 (XDIV) Price, Holdings, & News → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free XDIV Stock Alerts $105.73 +0.49 (+0.47%) (As of 12/10/2021) Add Compare Share Share Today's Range$104.79▼$105.9550-Day Range$105.73▼$105.7352-Week Range$79.45▼$106.82Volume2,000 shsAverage Volume3,414 shsMarket Capitalization$33.83 millionAssets Under Management$34.02 millionDividend Yield0.00%Net Expense Ratio0.58% Stock AnalysisStock Analysis Get Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 alerts: Email Address About Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 (NYSEARCA:XDIV)Read More XDIV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XDIV ETF News HeadlinesApril 19, 2024 | americanbankingnews.comMetaurus U.S. Equity Ex-Dividend Fund-Series 2027 (NYSEARCA:XDIV) Stock Price Up 0.5%March 16, 2024 | nasdaq.comUnilever PLC Common Stock (UL)April 27, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. February 28, 2024 | wsj.comDWS CROCI Equity Dividend Fund;ANovember 14, 2023 | wsj.comGoldman Sachs US Equity Dividend & Premium Fund;InstitutionalSeptember 16, 2023 | wsj.comDimensional World ex U.S. Core Equity 2 ETFJuly 18, 2023 | investing.comPacer Metaurus US Large Cap Dividend Multiplier 400 ETF (QDPL)May 20, 2023 | seekingalpha.comPRIF.PF Priority Income Fund, Inc. 6.625% Series F Term Preferred Stock due 2027April 27, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. May 16, 2023 | wsj.comBlackRock Equity Dividend Fund;Investor CSee More Headlines Receive XDIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerMetaurus Advisors Fund NameUS Equity EX Dividend Fund-Series 2027 Tax ClassificationPartnership Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:XDIV Inception Date2/15/2018 Fund ManagerRichard Sandulli, Jamie Greenwald, Donald M. Callahan, Sean A. Dillon WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkSolactive US Ex-Dividends Index Series 2027 CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$34.02 million Average Daily Volume$2,676.50 Discount/Premium-0.60% Administrator, Advisor and Custodian AdministratorSEI Investments Global Funds Services AdvisorMetaurus Advisors LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeWilmington Trust Company Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares320,000BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 ExpensesTypeXDIVLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.58%0.57%0.54%0.50%0.51%Other Expenses0.00%0.29%0.54%0.64%0.58%Total Expense0.58%0.64%0.70%0.74%0.70%Fee Waiver0.00%-0.19%-0.55%-0.68%-0.57%Net Expense0.58%0.61%0.60%0.58%0.58% Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 (XDIV)Full Holdings Details Similar ETFsETRACS 2x Leveraged US Value Factor TR ETNNYSEARCA:IWDLCalvert US Large-Cap Diversity, Equity and Inclusion Index ETFNYSEARCA:CDEIRoundhill Acquirers Deep Value ETFNYSEARCA:DEEPVictoryShares Developed Enhanced Volatility Wtd ETFNASDAQ:CIZGlobal X S&P 500 Risk Managed Income ETFNYSEARCA:XRMI XDIV ETF - Frequently Asked Questions How have XDIV shares performed in 2024? Metaurus U.S. Equity Ex-Dividend Fund-Series 2027's stock was trading at $105.73 at the start of the year. Since then, XDIV shares have increased by 0.0% and is now trading at $105.73. View the best growth stocks for 2024 here. What does XDIV invest in? Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 is a equity fund issued by Metaurus Advisors. XDIV focuses on large cap investments and follows the Solactive US Ex-Dividends Index Series 2027. The fund's investments total to approximately $34.02 million assets under management. What is the management fee for Metaurus U.S. Equity Ex-Dividend Fund-Series 2027? Metaurus U.S. Equity Ex-Dividend Fund-Series 2027's management fee is 0.58% and has no other recorded expenses or fee waivers. The net expense ratio for XDIV is 0.58%. How do I buy shares of Metaurus U.S. Equity Ex-Dividend Fund-Series 2027? Shares of XDIV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:XDIV) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
